Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 50 | 51 | +1 |
| Shares | 14.5M | 15.7M | +1.12M (+7.7%) |
| Value | $106.7M | $87.1M | −$19.6M (−18.4%) |
New holders (5)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Capital Holdings Plc | 1,000,000 | $5.56M | 0.04% |
| Millennium Management LLC | 17,153 | $95.4K | 0.00% |
| Dimensional Fund Advisors LP | 12,388 | $68.7K | 0.00% |
| Bourgeon Capital Management LLC | 7,000 | $38.9K | 0.01% |
| Allspring Global Investments Holdings, LLC | 1,371 | $7.62K | 0.00% |
Sold out (4)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of Montreal | 15,488 | $126.4K |
| Renaissance Technologies LLC | 15,700 | $115.0K |
| MetLife Investment Management | 8,932 | $65.6K |
| Metropolitan Life Insurance Co | 926 | $6.80K |